Mushrooms as care in Canada


Mushrooms will be care for BC woman suffering from depression

Mushrooms will be care for BC woman suffering from depression in BC. The Canadian government will allow patients who are not terminally ill to consume psychedelic mushrooms. Earlier, Oregon had also decided to give people access to shrooms for therapeutic reasons.

A 67-year old woman from Victoria, BC, will therefore be able to consume shrooms to treat ongoing trauma. The woman, Mona Strelaeff, stated: ‘I have struggled with anxiety, depression, and addiction for years. During my psilocybin therapy I went deep, way back to when I was a little girl and all those things that happened to me. All the unresolved trauma, it came back and I was beyond terrified, shaking uncontrollably, and crying’.

What is psychedelic therapy and who advocates it for Canadian patients?

Psylocybin is the active ingredient in shrooms which is illegal to produce, possess or sell in Canada. Usually, exceptions are made just for research purposes. But in a groundbreaking decision, Health Canada granted exemption to people with terminal illnesses. With Strelaeff’s exemption, shrooms-based therapies might become more common.

Spencer Hawkswell from nonprofit organisation TheraPsil stated: ‘Our mission is to help Canadians in need access medical psilocybin. We started with palliative Canadians for a number of reasons. The first is that you have the right to die in Canada, so surely you should have the right to try psilocybin. The second is that they didn’t have time to wait. We had identified some dying Canadians that had weeks or months to live. We had to help them first’.

TheraPsil is also advocating for psychedelic therapy in end-of-life care in Canada. Stralaeff suffered from trauma stemming from a previous breast cancer diagnosis as well as repressed childhood memories. She stated that thanks to psilocybin therapy she ‘conquered those tough memories’ and now she ‘ain’t scared’ of anything. TheraPsil is thus aiming to launch the first legal training program for doctors and therapists to use psychedelic therapy in January. A study by Ph.D. Gary L. Wenk published on Psychology Today shows that psilocybin demonstrates modest benefits for depressed people.